metaLead Therapeutics

Zurich, Switzerland Founded: 2022 • Age: 4 yrs
Next-generation medications against metal poisoning are developed.

About metaLead Therapeutics

metaLead Therapeutics is a Healthcare company based in Zurich (Switzerland) founded in 2022 by Michal Shoshan. Next-generation medications against metal poisoning are developed. metaLead Therapeutics has raised $170.02 thousand across 2 funding rounds from investors including Venture Kick. Its focus areas include Life Sciences, Toxicology and Drugs.

Company details

MetaLead Therapeutics was founded in 2022 in Zurich, Switzerland, within the biotechnology sector. Focus is placed on developing treatments for metal poisoning, with operations centered on chelation therapy. The lead compound targets lead (Pb) toxicity, which remains the primary treatment approach. Research and development activities are conducted to advance therapeutic options for heavy metal exposures.

  • Headquarters Zurich, Switzerland
  • Founders Michal Shoshan
  • Sectors
    Healthcare
Operational Areas
Key Metrics
  • Total Equity Funding
    $170.02K (USD)

    in 2 rounds

  • Latest Funding Round
    $159.94K (USD), Seed

    Mar 2023

  • Investors

Funding Insights of metaLead Therapeutics

metaLead Therapeutics has successfully raised a total of $170.02K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $159.94 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $170,018
  • Total Rounds 2
  • Last Round Seed β€” $159,944
  • First Round $10,074

    (May 2022)

  • Investors Count 1

All 2 funding rounds of metaLead Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2023$159,944Seed–Venture Kick
–
May 2022$10,074Seed–Venture Kick
–
Valuation history

1 investors in total: 1 institutional.

Investors in metaLead Therapeutics

metaLead Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
University backed startup accelerator
venturekick.chSchlieren, Switzerland
Premium access

Investor details for metaLead Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of metaLead Therapeutics

1 people are tracked at metaLead Therapeutics (1 in leadership).

NameRoleGroup
Michal Shoshan
FounderLeadership
Premium access

Complete people profiles for metaLead Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of metaLead Therapeutics

3 dated milestones of metaLead Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded metaLead Therapeutics is founded.
  2. Funding First funding round of $10K.
  3. Funding Latest funding round, Seed, of $160K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about metaLead Therapeutics

metaLead Therapeutics was founded in 2022.

metaLead Therapeutics is headquartered in Zurich, Switzerland.

metaLead Therapeutics is a funded company, having raised a total of $170.02K across 2 funding rounds to date. The company's 1st funding round was a Seed of $10.07K, raised on May 2022.

MetaLead Therapeutics was founded in 2022 in Zurich, Switzerland, within the biotechnology sector. Focus is placed on developing treatments for metal poisoning, with operations centered on chelation therapy. The lead compound targets lead (Pb) toxicity, which remains the primary treatment approach. Research and development activities are conducted to advance therapeutic options for heavy metal exposures.

metaLead Therapeutics has 1 investor. Key investors include Venture Kick.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available